{"id":"NCT03645863","sponsor":"Mitsubishi Tanabe Pharma Corporation","briefTitle":"Effects of Iron Supplements on the Pharmacokinetics of MT-6548","officialTitle":"A Clinical Pharmacological Study to Evaluate the Effects of Iron Supplements on the Pharmacokinetics of MT-6548 in Healthy Male Volunteers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-08-27","primaryCompletion":"2018-09-30","completion":"2018-09-30","firstPosted":"2018-08-24","resultsPosted":"2021-05-18","lastUpdate":"2023-12-13"},"enrollment":61,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Healthy"],"interventions":[{"type":"DRUG","name":"MT-6548","otherNames":["vadadustat","AKB-6548"]},{"type":"DRUG","name":"Iron supplement A","otherNames":[]},{"type":"DRUG","name":"Iron supplement B","otherNames":[]},{"type":"DRUG","name":"Iron supplement C","otherNames":[]},{"type":"DRUG","name":"Iron supplement D","otherNames":[]}],"arms":[{"label":"Cohort 1","type":"EXPERIMENTAL"},{"label":"Cohort 2","type":"EXPERIMENTAL"},{"label":"Cohort 3","type":"EXPERIMENTAL"}],"summary":"The objectives of this study are to investigate the pharmacokinetics and safety of MT-6548 co-administered with iron supplements in healthy male volunteers.","primaryOutcome":{"measure":"Area Under the Plasma Concentration-time Curve From Time Zero to Infinity(AUC0-âˆž) of Unchanged MT-6548","timeFrame":"Up to Day 8 (Cohort 1), Up to Day 5 (Cohort 2, 3)","effectByArm":[{"arm":"Cohort 1","deltaMin":105.3,"sd":17},{"arm":"Cohort 2","deltaMin":100.2,"sd":12.4},{"arm":"Cohort 3","deltaMin":129.3,"sd":18.1}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"MALE","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":17},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["34511184"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Abdominal discomfort","Diarrhoea"]}}